Cargando…
Sigmoid volvulus: outcomes of treatment and predictors of morbidity and mortality
PURPOSE: To analyze the treatment outcomes for sigmoid volvulus (SV) and identify risk factors of complications and mortality. METHODS: Observational study of all consecutive adult patients diagnosed with SV who were admitted from January 2000 to December 2020 in a tertiary university institution fo...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151547/ https://www.ncbi.nlm.nih.gov/pubmed/35028738 http://dx.doi.org/10.1007/s00423-022-02428-5 |
_version_ | 1784717506890432512 |
---|---|
author | Moro-Valdezate, David Martín-Arévalo, José Pla-Martí, Vicente García-Botello, Stephanie Izquierdo-Moreno, Ana Pérez-Santiago, Leticia Pedrós-Giménez, Jorge Manuel Villagrasa, Rosana Peña, Andrés Espí-Macías, Alejandro |
author_facet | Moro-Valdezate, David Martín-Arévalo, José Pla-Martí, Vicente García-Botello, Stephanie Izquierdo-Moreno, Ana Pérez-Santiago, Leticia Pedrós-Giménez, Jorge Manuel Villagrasa, Rosana Peña, Andrés Espí-Macías, Alejandro |
author_sort | Moro-Valdezate, David |
collection | PubMed |
description | PURPOSE: To analyze the treatment outcomes for sigmoid volvulus (SV) and identify risk factors of complications and mortality. METHODS: Observational study of all consecutive adult patients diagnosed with SV who were admitted from January 2000 to December 2020 in a tertiary university institution for conservative management, urgent or elective surgery. Primary outcomes were 30-day postoperative morbidity, mortality and 2-year overall survival (OS), including analysis of risk factors for postoperative morbidity or mortality and prognostic factors for 2-year OS. RESULTS: A total of 92 patients were included. Conservative management was performed in 43 cases (46.7%), 27 patients (29.4%) underwent emergent surgery and 22 (23.9%) were scheduled for elective surgery. Successful decompression was achieved in 87.8% of cases, but the recurrence rate was 47.2%. Mortality rates following episodes were higher for conservative treatment than for urgent or elective surgery (37.2%, 22.2%, 9.1%, respectively; p = 0.044). ASA score > III was an independent risk factor for complications (OR = 5.570, 95% CI = 1.740–17.829, p < 0.001) and mortality (OR = 6.139, 95% CI = 2.629–14.335, p < 0.001) in the 30 days after admission. Patients who underwent elective surgery showed higher 2-year OS than those with conservative treatment (p = 0.011). Elective surgery (HR = 2.604, 95% CI = 1.185–5.714, p = 0.017) and ASA score > III (HR = 0.351, 95% CI = 0.192–0.641, p = 0.001) were independent prognostic factors for 2-year OS. CONCLUSION: Successful endoscopic decompression can be achieved in most SV patients, but with the drawbacks of high recurrence, morbidity and mortality rates. Concurrent severe comorbidities and conservative treatment were independent prognostic factors for morbidity and survival in SV. |
format | Online Article Text |
id | pubmed-9151547 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-91515472022-06-01 Sigmoid volvulus: outcomes of treatment and predictors of morbidity and mortality Moro-Valdezate, David Martín-Arévalo, José Pla-Martí, Vicente García-Botello, Stephanie Izquierdo-Moreno, Ana Pérez-Santiago, Leticia Pedrós-Giménez, Jorge Manuel Villagrasa, Rosana Peña, Andrés Espí-Macías, Alejandro Langenbecks Arch Surg Original Article PURPOSE: To analyze the treatment outcomes for sigmoid volvulus (SV) and identify risk factors of complications and mortality. METHODS: Observational study of all consecutive adult patients diagnosed with SV who were admitted from January 2000 to December 2020 in a tertiary university institution for conservative management, urgent or elective surgery. Primary outcomes were 30-day postoperative morbidity, mortality and 2-year overall survival (OS), including analysis of risk factors for postoperative morbidity or mortality and prognostic factors for 2-year OS. RESULTS: A total of 92 patients were included. Conservative management was performed in 43 cases (46.7%), 27 patients (29.4%) underwent emergent surgery and 22 (23.9%) were scheduled for elective surgery. Successful decompression was achieved in 87.8% of cases, but the recurrence rate was 47.2%. Mortality rates following episodes were higher for conservative treatment than for urgent or elective surgery (37.2%, 22.2%, 9.1%, respectively; p = 0.044). ASA score > III was an independent risk factor for complications (OR = 5.570, 95% CI = 1.740–17.829, p < 0.001) and mortality (OR = 6.139, 95% CI = 2.629–14.335, p < 0.001) in the 30 days after admission. Patients who underwent elective surgery showed higher 2-year OS than those with conservative treatment (p = 0.011). Elective surgery (HR = 2.604, 95% CI = 1.185–5.714, p = 0.017) and ASA score > III (HR = 0.351, 95% CI = 0.192–0.641, p = 0.001) were independent prognostic factors for 2-year OS. CONCLUSION: Successful endoscopic decompression can be achieved in most SV patients, but with the drawbacks of high recurrence, morbidity and mortality rates. Concurrent severe comorbidities and conservative treatment were independent prognostic factors for morbidity and survival in SV. Springer Berlin Heidelberg 2022-01-14 2022 /pmc/articles/PMC9151547/ /pubmed/35028738 http://dx.doi.org/10.1007/s00423-022-02428-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Moro-Valdezate, David Martín-Arévalo, José Pla-Martí, Vicente García-Botello, Stephanie Izquierdo-Moreno, Ana Pérez-Santiago, Leticia Pedrós-Giménez, Jorge Manuel Villagrasa, Rosana Peña, Andrés Espí-Macías, Alejandro Sigmoid volvulus: outcomes of treatment and predictors of morbidity and mortality |
title | Sigmoid volvulus: outcomes of treatment and predictors of morbidity and mortality |
title_full | Sigmoid volvulus: outcomes of treatment and predictors of morbidity and mortality |
title_fullStr | Sigmoid volvulus: outcomes of treatment and predictors of morbidity and mortality |
title_full_unstemmed | Sigmoid volvulus: outcomes of treatment and predictors of morbidity and mortality |
title_short | Sigmoid volvulus: outcomes of treatment and predictors of morbidity and mortality |
title_sort | sigmoid volvulus: outcomes of treatment and predictors of morbidity and mortality |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151547/ https://www.ncbi.nlm.nih.gov/pubmed/35028738 http://dx.doi.org/10.1007/s00423-022-02428-5 |
work_keys_str_mv | AT morovaldezatedavid sigmoidvolvulusoutcomesoftreatmentandpredictorsofmorbidityandmortality AT martinarevalojose sigmoidvolvulusoutcomesoftreatmentandpredictorsofmorbidityandmortality AT plamartivicente sigmoidvolvulusoutcomesoftreatmentandpredictorsofmorbidityandmortality AT garciabotellostephanie sigmoidvolvulusoutcomesoftreatmentandpredictorsofmorbidityandmortality AT izquierdomorenoana sigmoidvolvulusoutcomesoftreatmentandpredictorsofmorbidityandmortality AT perezsantiagoleticia sigmoidvolvulusoutcomesoftreatmentandpredictorsofmorbidityandmortality AT pedrosgimenezjorgemanuel sigmoidvolvulusoutcomesoftreatmentandpredictorsofmorbidityandmortality AT villagrasarosana sigmoidvolvulusoutcomesoftreatmentandpredictorsofmorbidityandmortality AT penaandres sigmoidvolvulusoutcomesoftreatmentandpredictorsofmorbidityandmortality AT espimaciasalejandro sigmoidvolvulusoutcomesoftreatmentandpredictorsofmorbidityandmortality |